Interna Therapeutics
PrivateLast Round
Early Funding
Nov 4, 2024
Total Funding Raised
$10.25M
Company Overview
Interna Therapeutics is a biotechnology company that develops a universal intracellular delivery platform based on its proprietary Molecular Nano Motor (MNM) technology for the delivery of macromolecule drugs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Interna Therapeutics Comparables
Compare Interna Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CyGenica | 85% | |
| Sapreme Technologies BV | 83% | |
| Permeasis Therapeutics | 80% | |
Interna Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Nov 4, 2024 |
Key People
Founding team and executive leadership
Interna Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gates Foundation | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 3, 2026
Monthly visitors grew 169% MoM, reaching 2.8K.
Interna Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Interna Therapeutics's valuation, stock price, and market status.